跳至主要内容
临床试验/NCT07010354
NCT07010354招募中不适用

An International, Multi-centre Observational Study to Evaluate Safety, Performance, and Clinical Benefit of the BeFlow Iliac Covered Stent System

Bentley InnoMed GmbH7 个研究点 分布在 2 个国家目标入组 100 人开始时间: 2025年8月8日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
7
主要终点
Primary patency rate

研究概览

简要总结

This international, observational multi-centre study of the device BFI will monitor technical success of the implantation, data regarding clinical performance, clinical benefit, as well as potential unknown side effects pursuant to the Intended Purpose.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with an indication for permanent intraluminal placement in iliac arteries for restoring and improving the patency impaired by arteriosclerosis or other stenoses that may be treated by stenting according to the IFU of the BFI
  • Patient is capable and willing to sign an informed consent
  • Patients ≥18 years of age at the time of consent

排除标准

  • Patients with any contraindication according to the IFU
  • Previous stenting of the target vessel

结局指标

主要结局

Primary patency rate

时间窗: 12 months

次要结局

  • Rate of covered stent-related complications(1 month and 12 months)
  • Rate of technical success(up to 1 month)
  • Primary patency rate(up to 60 months)
  • Secondary patency rate(up to 60 months)
  • Primary assisted patency rate(up to 60 months)
  • Change of Rutherford Classification(up to 60 months)
  • Change of ABI(up to 60 months)
  • Freedom from TLR(up to 60 months)
  • Freedom from MACE(up to 60 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验